Oligomerization appears to be essential for the tumor suppressing activity of P53 because oligomerization-deficient P53 mutants cannot suppress the growth of carcinoma cell lines (Jeffrey et al., 1995; Kato et al., 2003). Here, TP53 is linked to carcinoma.